MIRA

MIRA

USD

MIRA Pharmaceuticals Inc. Common Stock

$1.570-0.120 (-7.101%)

Echtzeitkurs

Healthcare
Drug Manufacturers - General
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.690

Hoch

$1.725

Tief

$1.560

Volumen

0.04M

Unternehmensfundamentaldaten

Marktkapitalisierung

32.7M

Branche

Drug Manufacturers - General

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

3.18M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.73Aktuell $1.570Hoch $2.45

Ähnliche Nachrichten

AccessWire

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / October 24, 2025 /

Mehr anzeigen
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication